THE INDIAN PHARMACIST Official Circular Pharmacy Logo THE INDIAN PHARMACISTLearn. Explore. Practise. Excel.
MEDICINE MONOGRAPH CODE: [11.16] ID: TIP-MED-000453 ⚠️ HIGH-ALERT / SPECIALIST SUPERVISION

Nortriptyline & Clomipramine Hydrochloride

Active Ingredient / Scientific Identity: Nortriptyline & Clomipramine Hydrochloride • Class: Secondary & Tertiary Amine Tricyclic Antidepressants — TCAs (Schedule H | NLEM 2022 [Clomipramine])

⚖️ Compare Profile
Generic / Entity NameNortriptyline & Clomipramine Hydrochloride ([11.16])
Verified Indian Brands / RefGeneric Compendial Entry (No Commercial Brand Claimed)
Pharmacological ClassSecondary & Tertiary Amine Tricyclic Antidepressants — TCAs (Schedule H | NLEM 2022 [Clomi
Available Dosage FormsStandard hospital formulary strengths
Regulatory ClassificationSchedule H1 (Rx — 3-Year Register Retention & Red-Border Warning)
Key Warning & Review DateHigh-alert hospital specialist agent; administer under close physiological and laboratory monitoring.
Reviewed: 2026-11-10
Safety Matrix:⚖️ Legal Status: Schedule H1 (Rx — 3-Year Register Retention & Red-Bo🚨 Clinically High-Alert: Independent Dose & Route Verification Required👨‍⚕️ Specialist-Supervised Therapy

1. Clinical & Scientific Overview

Nortriptyline & Clomipramine Hydrochloride (TIP-MED-000453, Reference Code [11.16]) is classified under Neurology Medicines as a Secondary & Tertiary Amine Tricyclic Antidepressants — TCAs (Schedule H | NLEM 2022 [Clomipramine]). Within the Indian regulatory and compendial framework, it is governed under Schedule H1 (Rx — 3-Year Register Retention & Red-Border Warning).

Verified Indian Market Examples / Compendial Status:
Representative Indian Formulations (for identification only): Nortriptyline: Sensival (Wallace), Primox (Sun); FDCs with Pregabalin/Gabapentin + Methylcobalamin (Pregabalin-NT, Gabapin-NT). | Strengths: Nortriptyline Tablets: 10 mg, 25 mg. Clomipramine Tablets/Capsules: 10 mg, 25 mg, 50 mg, 75 mg SR
Representative Indian Formulations (for identification only): Nortriptyline: Sensival (Wallace), Primox (Sun); FDCs with Pregabalin/Gabapentin + Methylcobalamin (Pregabalin-NT, Gabapin-NT). | Strengths: Nortriptyline Tablets: 10 mg, 25 mg. Clomipramine Tablets/Capsules: 10 mg, 25 mg, 50 mg, 75 mg SR
Dosage Forms & Available Strengths:
Standard hospital formulary strengths
Routes: Intravenous / Parenteral / Oral

3. Mechanism of Action & Pharmacodynamics

Established pharmacological class action (Secondary & Tertiary Amine Tricyclic Antidepressants — TCAs (Schedule H | NLEM 2022 [Clomipramine])): targets primary receptor, enzyme, ion-channel, or cellular pathway to achieve therapeutic efficacy in Nortriptyline: Neuropathic pain (diabetic neuropathy, post-herpetic neuralgia, trigeminal neuralgia), migraine prophylaxis, and depression (Nortriptyline is the active demethylated metabolite of Amitriptyline and causes ~40% less M1 anticholinergic, H1 sedative, and alpha-1 orthostatic toxicity than Amitriptyline!).

4. Therapeutic Indications & Evidence-Supported Uses

  • Nortriptyline: Neuropathic pain (diabetic neuropathy, post-herpetic neuralgia, trigeminal neuralgia), migraine prophylaxis, and depression (Nortriptyline is the active demethylated metabolite of Amitriptyline and causes ~40% less M1 anticholinergic, H1 sedative, and alpha-1 orthostatic toxicity than Amitriptyline!)

🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.

5. Educational Dosage Context, Formulations & Administration

Educational Dosing & Regimen Summary: Nortriptyline (Neuropathic Pain / Migraine): Start 10 mg PO at bedtime (1–2 hours before sleep), titrate every 1–2 weeks to 25–50 mg HS (Depression: up to 75–100 mg/d). (Duration: Neuropathic pain/Migraine: 3–6+ months. OCD: >=12 months; taper gradually over 4 weeks when stopping)

Administration & Meal Timing: Oral (PO) | Food & Meal Timing: Take at BEDTIME (or 1–2 hours before desired sleep time to reduce morning hangover drowsiness); take Clomipramine with food to reduce GI nausea | Best Time of Day: Bedtime / Evening (8:00–9:00 PM)

6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment

Absorption & Disposition:
Hospital pharmacokinetic profile; monitor therapeutic response and organ clearance.
Metabolism & Biotransformation:
Renal: Hydroxylated active metabolites (10-OH-nortriptyline) accumulate in CKD Stage 4–5 — use lowest dose (10 mg HS). Hepatic: Reduce dose by 50% in hepatic impairment
Elimination & Renal Adjustment:
Renal: Hydroxylated active metabolites (10-OH-nortriptyline) accumulate in CKD Stage 4–5 — use lowest dose (10 mg HS). Hepatic: Reduce dose by 50% in hepatic impairment
Hepatic Impairment Considerations:
Renal: Hydroxylated active metabolites (10-OH-nortriptyline) accumulate in CKD Stage 4–5 — use lowest dose (10 mg HS). Hepatic: Reduce dose by 50% in hepatic impairment

7. Contraindications, Precautions & High-Risk Warnings

Contraindications & Red-Flag Precautions:
  • CONTRAINDICATED in recent myocardial infarction, bundle-branch / AV heart block, QTc prolongation, narrow-angle glaucoma, severe urinary retention (BPH), Child–Pugh C liver failure, and within 14 days of MAO inhibitors (Linezolid, Selegiline — fatal Serotonin Syndrome!)

Key Clinical Precautions: High-alert hospital specialist agent; administer under close physiological and laboratory monitoring.

8. Adverse Effects Profile

Common & Mechanism-Related Adverse Effects:
  • Dry mouth, constipation, blurred vision, drowsiness, weight gain, orthostatic dizziness, sinus tachycardia, sexual dysfunction, sweating (Clomipramine > Nortriptyline)
Serious / Dose-Limiting Adverse Effects:
  • Monitor for hemodynamic instability, organ toxicity, or severe hypersensitivity.

9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions

  • POTENT CYP2D6 INHIBITORS (Fluoxetine, Paroxetine, Bupropion, Terbinafine, Duloxetine, Quinidine, Cimetidine) increase Nortriptyline and Clomipramine plasma levels 3–5-fold -> acute TCA cardiotoxicity!
  • Fluvoxamine (CYP1A2/2C19 inhibitor) quadruples Clomipramine levels!

10. Clinical Monitoring, Patient Counselling & Storage

Clinical & Laboratory Monitoring: Continuous clinical, hemodynamic, and organ-function laboratory monitoring.

Pharmacist Patient Counselling Points:

  • COUNTER DUPLICATION CHECK: Many Indian neuropathy prescriptions combine 'Gabapin-NT' or 'Pregabalin-NT' (which ALREADY contain Nortriptyline 10 mg!) with a separate 'Sensival' or 'Tryptomer' tablet — always check FDC compositions to prevent double TCA dosing! Take 1–2 hours before bedtime so morning drowsiness wears off before waking

Storage, Stability & Dispensing Safeguards: Store in original moisture-protected packaging below 25°C–30°C (or 2°C–8°C cold chain if parenteral/biological vial specified in strengths: Nortriptyline Tablets: 10 mg, 25 mg. Clomipramine Tablets/Capsules: 10 mg, 25 mg, 50 mg, 75 mg SR). Missed-Dose Rule: Take at bedtime if remembered; skip if not remembered until the next morning (taking in the morning causes severe daytime sedation)

11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)

THE 12-STEP ORAL DRUG JOURNEY THROUGH THE HUMAN BODY (LADME) Note: IV bolus enters Step 6 directly (F = 100%); Sublingual & Transdermal routes bypass Step 4–5 Portal First-Pass Metabolism 1. Oral Administration • Tablet / Capsule swallowed • Gastric emptying to duodenum pH 1.5–3.5 (Stomach) 2. Disintegration & Dissolution • Tablet breaks into granules • API dissolves in GI fluid Noyes-Whitney Dissolution Rate 3. GI Epithelial Absorption • Crosses intestinal villi • Passive / Active / P-gp efflux Small Intestine (Large Surface Area) 4. Portal Circulation • Mesenteric veins → Portal vein • Delivers blood to liver sinusoids Pre-systemic Venous Conduit 5. First-Pass Metabolism • Gut & hepatic CYP450 extraction • High: GTN, Propranolol, Morphine Determines Bioavailability (F = f_a × (1-E_H)) 6. Systemic Circulation • Hepatic vein → IVC → Heart • Unbound vs Albumin-bound drug Only FREE drug is active 7–8. Tissue Distribution (Vd) • Capillary permeation to organs • Blood-Brain & Placental barriers Vd = Dose / C_0 (L or L/kg) 9. Target Site of Action • Receptors (GPCR, Ion channel) • Enzymes & Carrier Transporters Pharmacodynamic Effect (E_max, EC50) 10. Hepatic Biotransformation • Phase I (CYP450 Oxidation/Hydrolysis) • Phase II (Glucuronidation/Sulfation) Converts lipophilic drug → hydrophilic metabolite 11. Renal & Biliary Elimination • Nephron: Filtration + Secretion − Reabsorption • Biliary excretion & Enterohepatic recycling Total Clearance CL_tot = CL_renal + CL_hepatic 12. Excretion from the Body • Urine (Primary polar metabolite route) • Bile/Faeces, Expired Air, Sweat, Milk Elimination Half-Life t1/2 = (0.693 × Vd) / CL
svg-v339-01-adme-12-step-journey — 8.1 Complete 12-Step Journey of an Orally Administered Drug (ADME): Figure 8.1: The 12-step physiological journey of a typical orally administered solid dosage form through Liberation, Absorption, Distribution, Metabolism, and Excretion (LADME). Note: Parenteral (IV), sublingual, and inhalational routes bypass gastrointestinal absorption and/or hepatic first-pass metabolism.

12. Authoritative References, Regulatory Sources & Editorial Disclaimer

Primary Compendial & Guideline Reference: Indian Pharmacopoeia (IP 2022) • NFI • CDSCO • NCBI Bookshelf

Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)

Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: VERIFIED_EDUCATIONAL_CONTENT

Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.